abstract |
The present invention relates to valsartan tablets for oral administration comprising valsartan, at least two different disintegrants, and optionally hydrochlorthiazide (HCTZ); and processes of preparation thereof. The present invention also relates to methods of treating hypertension administering to a mammal a valsartan tablet disclosed herein. |